Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do.

Szekanecz Z, Kerekes G, Végh E, Kardos Z, Baráth Z, Tamási L, Shoenfeld Y.

Autoimmun Rev. 2016 Jul;15(7):756-69. doi: 10.1016/j.autrev.2016.03.014. Review.

PMID:
26979271
2.

Rheumatoid arthritis and metabolic syndrome.

Kerekes G, Nurmohamed MT, González-Gay MA, Seres I, Paragh G, Kardos Z, Baráth Z, Tamási L, Soltész P, Szekanecz Z.

Nat Rev Rheumatol. 2014 Nov;10(11):691-6. doi: 10.1038/nrrheum.2014.121. Review.

PMID:
25090948
3.

Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study.

Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E.

Rheumatology (Oxford). 2014 Nov;53(11):2035-43. doi: 10.1093/rheumatology/keu236.

PMID:
24917564
4.

Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients.

Vincze M, Dér H, Kerekes G, Szodoray P, Zeher M, Dankó K, Soltész P.

Clin Rheumatol. 2014 Nov;33(11):1635-41. doi: 10.1007/s10067-014-2561-y.

PMID:
24615538
5.

Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, Dankó K, Szamosi S, Németh Á, Soltész P, Szücs G.

Arthritis Res Ther. 2013;15(5):R105.

6.

Cardiac manifestations in a young man with Takayasu arteritis associated with antiphospholipid syndrome.

Laczik R, Galajda Z, Dér H, Végh J, Kerekes G, Szekanecz Z, Soltész P, Szomják E.

Isr Med Assoc J. 2012 Dec;14(12):768-70. No abstract available.

7.

Validated methods for assessment of subclinical atherosclerosis in rheumatology.

Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Végh E, Shoenfeld Y, McInnes I, Szekanecz Z.

Nat Rev Rheumatol. 2012 Feb 21;8(4):224-34. doi: 10.1038/nrrheum.2012.16. Review.

PMID:
22349611
8.

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2011 Mar;13(3):147-52.

9.

Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.

Soltész P, Kerekes G, Dér H, Szücs G, Szántó S, Kiss E, Bodolay E, Zeher M, Timár O, Szodoray P, Szegedi G, Szekanecz Z.

Autoimmun Rev. 2011 May;10(7):416-25. doi: 10.1016/j.autrev.2011.01.004. Review.

PMID:
21281743
10.

Assessment of subclinical vascular disease associated with ankylosing spondylitis.

Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S.

J Rheumatol. 2011 Apr;38(4):723-9. doi: 10.3899/jrheum.100668.

PMID:
21239756
11.

Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.

Kemény-Beke Á, Gesztelyi R, Bodnár N, Zsuga J, Kerekes G, Zsuga M, Biri B, Kéki S, Szodoray P, Berta A, Szekanecz Z, Szántó S.

Joint Bone Spine. 2011 Mar;78(2):184-7. doi: 10.1016/j.jbspin.2010.05.009.

PMID:
20620092
12.

Immunological parameters, including CXCL8 (IL-8) characterize cerebro- and cardiovascular events in patients with peripheral artery diseases.

Szomjak E, Der H, Kerekes G, Veres K, Csiba L, Toth J, Peter M, Soltesz P, Szodoray P.

Scand J Immunol. 2010 Apr;71(4):283-91. doi: 10.1111/j.1365-3083.2010.02368.x.

13.

Vascular effects of biologic agents in RA and spondyloarthropathies.

Szekanecz Z, Kerekes G, Soltész P.

Nat Rev Rheumatol. 2009 Dec;5(12):677-84. doi: 10.1038/nrrheum.2009.219. Review.

PMID:
19901918
14.

Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis.

Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Shoenfeld Y, Szekanecz Z.

Ann N Y Acad Sci. 2009 Sep;1173:814-21. doi: 10.1111/j.1749-6632.2009.04645.x.

PMID:
19758233
15.

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.

Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Szegedi G, Shoenfeld Y, Szekanecz Z.

Clin Rheumatol. 2009 Jun;28(6):705-10. doi: 10.1007/s10067-009-1095-1.

PMID:
19319624
16.

A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.

Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, Szegedi G, Szekanecz Z.

Clin Rheumatol. 2009 Jun;28(6):655-62. doi: 10.1007/s10067-009-1118-y.

PMID:
19224126
17.

[Multiple obliterative vascular disease. Challenge in diagnosis and in treatment].

Szomják E, Dér H, Kerekes G, Veres K, Tóth J, Olvasztó S, Herczku C, Soltész P.

Orv Hetil. 2008 Nov 9;149(45):2135-40. doi: 10.1556/OH.2008.28361. Hungarian.

PMID:
18977741
18.

Catastrophic antiphospholipid syndrome (Asherson's syndrome) associated with cytokeratin 7-positive endometrial cancer.

Soltész P, Veres K, Szomják E, Kerekes G, Dér H, Sándor Z, Dezso B, Dévényi K, Szekanecz Z.

Isr Med Assoc J. 2007 Dec;9(12):891-3. No abstract available.

19.

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.

J Rheumatol. 2008 Mar;35(3):398-406.

PMID:
18203326
20.

[A rare metastasis of small bowel carcinoma: ovarian tumour].

Nagy A, Kerekes G, Erényi A, Kocsis J.

Magy Seb. 2007 Aug;60(4):222-5. Hungarian.

PMID:
17932001

Supplemental Content

Loading ...
Support Center